Primary Site >> Liver Cancer
Gene >> CA9
| 1. | |||||||||||
| Journal: | Hokkaido Igaku Zasshi. 1997 Mar;72(2):211-24. | ||||||||||
| Title: | [Detectability and diagnostic criteria of p53 gene mutations in human oral squamous cell carcinoma using yeast functional assay]. | ||||||||||
| Author: | Kashiwazaki, H | ||||||||||
| PMID: | 9145313 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Lett. 2005 Jan 10;217(1):43-52. | ||||||||||
| Title: | Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. | ||||||||||
| Author: | Kok, Sang-Heng|Cheng, Shih-Jung|Hong, Chi-Yuan|Lee, Jang-Jaer|Lin, Sze-Kwan|Kuo, Ying-Shiung|Chiang, Chun-Pin|Kuo, Mark Yen-Ping | ||||||||||
| PMID: | 15596295 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):473-82. | ||||||||||
| Title: | Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. | ||||||||||
| Author: | van Laarhoven, Hanneke W M|Kaanders, Johannes H A M|Lok, Jasper|Peeters, Wenny J M|Rijken, Paul F J W|Wiering, Bastiaan|Ruers, Theo J M|Punt, Cornelis J A|Heerschap, Arend|van der Kogel, Albert J | ||||||||||
| PMID: | 16242253 | ||||||||||
| 4. | |||||||||||
| Journal: | Planta Med. 2010 Apr;76(6):613-9. | ||||||||||
| Title: | Cytotoxic lignan esters from Cinnamomum osmophloeum. | ||||||||||
| Author: | Chen, Tai-Hung|Huang, Yu-Hao|Lin, Jhih-Jhang|Liau, Bing-Chung|Wang, Sheng-Yang|Wu, Yang-Chang|Jong, Ting-Ting | ||||||||||
| PMID: | 19950049 | ||||||||||
| 5. | |||||||||||
| Journal: | Korean J Physiol Pharmacol. 2010 Oct;14(5):331-6. | ||||||||||
| Title: | CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1alpha in Hepatoma Cells. | ||||||||||
| Author: | Lee, Kyoung-Hwa | ||||||||||
| PMID: | 21165333 | ||||||||||
| 6. | |||||||||||
| Journal: | World J Clin Oncol. 2012 Jun 10;3(6):82-91. | ||||||||||
| Title: | Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro. | ||||||||||
| Author: | Kockar, Feray|Yildrim, Hatice|Sagkan, Rahsan Ilikci|Hagemann, Carsten|Soysal, Yasemin|Anacker, Jelena|Hamza, Ahmed Ayad|Vordermark, Dirk|Flentje, Michael|Said, Harun M | ||||||||||
| PMID: | 22724087 | ||||||||||
| 7. | |||||||||||
| Journal: | Clin Cancer Res. 2013 Mar 15;19(6):1557-66. | ||||||||||
| Title: | Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. | ||||||||||
| Author: | Zhu, Andrew X|Ancukiewicz, Marek|Supko, Jeffrey G|Sahani, Dushyant V|Blaszkowsky, Lawrence S|Meyerhardt, Jeffrey A|Abrams, Thomas A|McCleary, Nadine Jackson|Bhargava, Pankaj|Muzikansky, Alona|Sheehan, Susan|Regan, Eileen|Vasudev, Eamala|Knowles, Michelle| | ||||||||||
| PMID: | 23362324 | ||||||||||
| 8. | |||||||||||
| Journal: | Acta Pharmacol Sin. 2013 Sep;34(9):1208-16. | ||||||||||
| Title: | Disulfiram deregulates HIF-alpha subunits and blunts tumor adaptation to hypoxia in hepatoma cells. | ||||||||||
| Author: | Park, Hye-joon|Kim, Min-sung|Cho, Kumsun|Yun, Jang-hyuk|Choi, Yong-joon|Cho, Chung-hyun | ||||||||||
| PMID: | 23852087 | ||||||||||
| 9. | |||||||||||
| Journal: | Histopathology. 2015 Oct;67(4):442-50. | ||||||||||
| Title: | Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. | ||||||||||
| Author: | Lai, Jin-Ping|Conley, Andrew|Knudsen, Beatrice S|Guindi, Maha | ||||||||||
| PMID: | 25425262 | ||||||||||
| 10. | |||||||||||
| Journal: | Mod Pathol. 2016 Sep;29(9):1038-49. | ||||||||||
| Title: | Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. | ||||||||||
| Author: | Rhee, Hyungjin|Nahm, Ji Hae|Kim, Haeryoung|Choi, Gi Hong|Yoo, Jeong Eun|Lee, Hye Sun|Koh, Myoung Ju|Park, Young Nyun | ||||||||||
| PMID: | 27312064 | ||||||||||
| 11. | |||||||||||
| Journal: | Sci Rep. 2017 Jun 30;7(1):4466. | ||||||||||
| Title: | 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma. | ||||||||||
| Author: | Hua, Kuo-Tai|Liu, Yu-Fan|Hsu, Chia-Lang|Cheng, Tsu-Yao|Yang, Ching-Yao|Chang, Jeng-Shou|Lee, Wei-Jiunn|Hsiao, Michael|Juan, Hsueh-Fen|Chien, Ming-Hsien|Yang, Shun-Fa | ||||||||||
| PMID: | 28667334 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Oncol. 2017 Oct;51(4):1179-1190. | ||||||||||
| Title: | Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelialmesenchymal transition in hepatocellular carcinoma. | ||||||||||
| Author: | Hyuga, Satoshi|Wada, Hiroshi|Eguchi, Hidetoshi|Otsuru, Toru|Iwgami, Yoshifumi|Yamada, Daisaku|Noda, Takehiro|Asaoka, Tadafumi|Kawamoto, Koichi|Gotoh, Kunihito|Takeda, Yutaka|Tanemura, Masahiro|Umeshita, Koji|Doki, Yuichiro|Mori, Masaki | ||||||||||
| PMID: | 28849188 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncotarget. 2017 Oct 26;8(59):99359-99371. | ||||||||||
| Title: | Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. | ||||||||||
| Author: | Nahm, Ji Hae|Rhee, Hyungjin|Kim, Haeryoung|Yoo, Jeong Eun|San Lee, Jee|Jeon, Youngsic|Choi, Gi Hong|Park, Young Nyun | ||||||||||
| PMID: | 29245907 | ||||||||||
| 14. | |||||||||||
| Journal: | Oncoimmunology. 2018 Mar 26;7(7):e1445452. | ||||||||||
| Title: | pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma. | ||||||||||
| Author: | Kuchuk, Olga|Tuccitto, Alessandra|Citterio, Davide|Huber, Veronica|Camisaschi, Chiara|Milione, Massimo|Vergani, Barbara|Villa, Antonello|Alison, Malcolm Ronald|Carradori, Simone|Supuran, Claudiu T|Rivoltini, Licia|Castelli, Chiara|Mazzaferro, Vincenzo | ||||||||||
| PMID: | 29900055 | ||||||||||
| 15. | |||||||||||
| Journal: | Gut Liver. 2018 Sep 21. pii: gnl17569. | ||||||||||
| Title: | Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis. | ||||||||||
| Author: | Choi, Jiwoon|Chung, Taek|Rhee, Hyungjin|Kim, Young-Joo|Jeon, Youngsic|Yoo, Jeong Eun|Noh, Songmi|Han, Dai Hoon|Park, Young Nyun | ||||||||||
| PMID: | 29938458 | ||||||||||
| 16. | |||||||||||
| Journal: | PLoS One. 2018 Jul 16;13(7):e0200855. | ||||||||||
| Title: | Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis. | ||||||||||
| Author: | Finkelmeier, Fabian|Canli, Ozge|Peiffer, Kai-Henrik|Walter, Dirk|Tal, Andrea|Koch, Christine|Pession, Ursula|Vermehren, Johannes|Trojan, Jorg|Zeuzem, Stefan|Piiper, Albrecht|Greten, Florian R|Grammatikos, Georgios|Waidmann, Oliver | ||||||||||
| PMID: | 30011326 | ||||||||||
| 17. | |||||||||||
| Journal: | Clin Cancer Res. 2018 Sep 6. pii: 1078-0432.CCR-18-0847. | ||||||||||
| Title: | A Phase II and Biomarker Study of Sorafenib Combined with FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC). | ||||||||||
| Author: | Goyal, Lipika|Zheng, Hui|Abrams, Thomas A|Miksad, Rebecca|Bullock, Andrea J|Allen, Jill N|Yurgelun, Matthew B|Clark, Jeffrey W|Kambadakone, Avinash|Muzikansky, Alona|Knowles, Michelle|Galway, Aralee|Afflitto, Anthony James|DiNicola, Caroline F|Regan, Eile | ||||||||||
| PMID: | 30190369 | ||||||||||
| 18. | |||||||||||
| Journal: | Wellcome Open Res. 2018 Sep 26;3:126. | ||||||||||
| Title: | Glucose and glutamine availability regulate HepG2 transcriptional responses to low oxygen. | ||||||||||
| Author: | Lai, Alvina G|Forde, Donall|Chang, Wai Hoong|Yuan, Fang|Zhuang, Xiaodong|Orbegozo Rubio, Claudia|Song, Chun-Xiao|McKeating, Jane A | ||||||||||
| PMID: | 30345392 | ||||||||||